Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival

Journal of Clinical Pathology

Volumn 57, Issue 9, 2004, Pages 938-942

  Zauber, N P ^a   Wang, C ^a   Lee, P S ^a   Redondo, T C ^a   Bishop, D T ^b   Goel, A ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DELETED IN COLON CANCER PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; STAINING;

AGED; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; GENES, APC; GENES, DCC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SURVIVAL RATE;

EID: 4444343743     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.017814     Document Type: Article

References (23)

1. Fisher ER, Sass R, Palekar A, et al. Dukes' classification revisited. Cancer 1989;64:2354-60.
2. Compton CC. Colorectal carcinoma: diagnostic, prognostic and molecular features. Mod Pathol 2003;16:376-88.
3. Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus Levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
4. Compton CC, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint committee on cancer prognostic factors consensus conference. Cancer 2000;88:1739-57.
5. Spirio L, Joslyn G, Nelson L, et al. A CA repeat 30-70 kb downstream from the adenomatous polyposis coli (APC) gene. Nucleic Acids Res 1991;19:6348.
6. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
7. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
8. Zauber NP, Sabbath-Solitare M, Marotta S, et al. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol 2001;193:303-9.
9. Zauber NP, Sabbath-Solitare M, Marotta S, et al. Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue far use in a polymerase chain reaction to assess loss of heterozygosity. Mol Diagn 1999;4:29-34.
10. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749-56.
11. Loukola A, Eklin K, Laiho P, et al. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 2001;61:4545-59.
12. Burmer GC, Loeb LA. Mutations in the K-ras2 oncogene during progressive stages of human colon cancer. Proc Natl Acad Sci U S A 1989;86:2403-7.
13. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637-42.
14. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-9.
15. Merrie AEH, Rij AM, Dennett ER, et al. Prognostic significance of occult metastases in colon cancer. Dis Colon Rectum 2003;46:221-31.
16. Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999;5:2063-8.
17. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002;45:750-6.
18. Jeffers MD, O'Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
19. Cutait R, Alves VAF, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-20.
20. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 1991;6:325-44.
21. Pheby DFH, Levine DF, Pitcher RW, et al. Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit. J Clin Pathol 2004;57:43-7.
22. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003;10:213-18.
23. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21:2912-19.